Xencor Hits 80-Plus Relative Strength Rating Benchmark
| XNCR Stock | USD 24.13 0.34 1.43% |
Slightly above 54% of Xencor's retail investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Xencor Inc suggests that some traders are interested. Xencor's investing sentiment overview a quick insight into current market opportunities from investing in Xencor Inc. Many technical investors use Xencor Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Xencor |
Xencor shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.
Read at investors.com
 |
Xencor Fundamental Analysis
We analyze Xencor's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xencor using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xencor based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Xencor is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Xencor Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xencor stock to make a market-neutral strategy. Peer analysis of Xencor could also be used in its relative valuation, which is a method of valuing Xencor by comparing valuation metrics with similar companies.
Peers
Xencor Related Equities
| ANAB | AnaptysBio | 9.28 | ||||
| LRMR | Larimar Therapeutics | 4.24 | ||||
| MLYS | Mineralys Therapeutics, | 4.08 | ||||
| IDYA | Ideaya Biosciences | 3.34 | ||||
| EWTX | Edgewise Therapeutics | 2.55 | ||||
| MGTX | MeiraGTx Holdings | 2.39 | ||||
| VRDN | Viridian Therapeutics | 2.18 | ||||
| SNDX | Syndax Pharmaceuticals | 2.06 | ||||
| MRUS | Merus BV | 2.03 | ||||
| PCVX | Vaxcyte | 1.87 | ||||
| PTGX | Protagonist Therapeutics | 1.51 | ||||
| ERAS | Erasca | 1.48 | ||||
| KROS | Keros Therapeutics | 1.13 | ||||
| STRO | Sutro Biopharma | 1.04 | ||||
| NUVL | Nuvalent | 0.99 | ||||
| GLUE | Monte Rosa | 0.84 | ||||
| KURA | Kura Oncology | 0.58 | ||||
| ACLX | Arcellx | 0.48 | ||||
| REPL | Replimune | 0.48 |
Additional Tools for Xencor Stock Analysis
When running Xencor's price analysis, check to measure Xencor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xencor is operating at the current time. Most of Xencor's value examination focuses on studying past and present price action to predict the probability of Xencor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xencor's price. Additionally, you may evaluate how the addition of Xencor to your portfolios can decrease your overall portfolio volatility.